Award

Reagents and Bioinformatics analysis

NHS GRAMPIAN

This public procurement record has 1 release in its history.

Award

23 Jul 2025 at 00:00

Summary of the contracting process

NHS Grampian has concluded a procurement process for the supply of reagents and bioinformatics analysis related to Next Generation Sequencing (NGS) kits, essential for several national health services, including cancer and cardiac testing. The procurement, which falls under the health category and took place in Aberdeen, utilised a limited procedure, directly awarding the contract to SOPHiA GENETICS Ltd. This decision was made to ensure continuity in patient care, avoiding the significant delays and costs that would be incurred with alternate suppliers. The contract was signed on 21 July 2025, with an estimated value of £376,349 for the 2024-25 financial year.

This tender presents significant opportunities for businesses specialising in advanced genetic analysis and bioinformatics solutions within the health sector. Companies with established, integrated bioinformatics systems will find themselves well-suited to supply similar requisites, provided they can demonstrate specialised products that meet stringent healthcare standards. The contract's framework underscores the importance of established technical solutions and the potential for growth in servicing the public health system's complex needs, particularly those offering unique and validated products capable of enhancing healthcare service delivery.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Reagents and Bioinformatics analysis

Notice Description

Next Generation Sequencing (NGS) kits

Lot Information

Lot 1

Award value estimated based on previous spend for 2023-24 financial year. This is a direct award to the existing supplier to save a significant amount of rework that would be required if the genetics lab was to switch to an alternative supplier. This will cover the spend for 2024-25 financial year. It is vital that the supply of these items is uninterrupted as any delay will impact on patient care including cancer surgery / treatments, stem cell transplants for patients with primary immune deficiencies and bone marrow failure and correct patient management to prevent irreversible brain damage in metabolic conditions.

Procurement Information

We have a number of services within the department that use Next Generation Sequencing (NGS) kits supplied by SOPHiA Genetics. These services are funded by National Services division (NSD) and the Aberdeen laboratory provides National services for Hereditary Breast, Ovarian and prostate cancer, Cardiac arrhythmias and Whole exome sequencing (for metabolic, gastrohepatology, chromosome breakage / inherited bone marrow failure and eye disorders) using these SOPHiA kits. These are essential established reagents used in these testing pathways, having previously undergone extensive validation processes within the laboratory. Purchase of alternative reagents would involve delay to testing as additional extensive validation work would need to be undertaken before use. An integral bioinformatics solution, SOPHiA DDM, is included in the price of these SOPHiA kits which provides cost-effective, streamlined analysis for these patient samples. In addition, SOPHiA DDM is used to analyse NGS data for other rare and inherited conditions using tailored analysis pipelines. This includes Primary Immune Deficiencies, Familial Hypercholesterolaemia and tumour testing for metastatic prostate cancer. This is charged on a cost per sample upload basis and allows clinical scientists to analyse the data in an efficient manner without the need for specialist bioinformaticians. Purchase of bioinformatics services from another provider would take a significant amount of time for the validation work required to ensure accurate results are obtained and would incur significant costs for extensive validation. Furthermore, additional staff would be required to perform the bioinformatics processes that would be required in the absence of the SOPHiA DDM platform for all of the national genetics services mentioned above. It is vital that the supply of these items is uninterrupted as any delay will impact on patient care including cancer surgery / treatments, stem cell transplants for patients with primary immune deficiencies and bone marrow failure and correct patient management to prevent irreversible brain damage in metabolic conditions.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000805164
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL535288
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33696500 - Laboratory reagents

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£376,349 £100K-£500K

Notice Dates

Publication Date
23 Jul 20257 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
21 Jul 20257 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS GRAMPIAN
Contact Name
Not specified
Contact Email
simon.ogg@nhs.scot
Contact Phone
+44 3454566000

Buyer Location

Locality
ABERDEEN
Postcode
AB15 6RE
Post Town
Aberdeen
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM5 North Eastern Scotland
Small Region (ITL 3)
TLM50 Aberdeen City and Aberdeenshire
Delivery Location
TLM50 Aberdeen City and Aberdeenshire

Local Authority
Aberdeen City
Electoral Ward
Kingswells/Sheddocksley/Summerhill
Westminster Constituency
Aberdeen North

Supplier Information

Number of Suppliers
1
Supplier Name

SOPHIA GENETICS

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000805164-2025-07-23T00:00:00Z",
    "date": "2025-07-23T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000805164",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-167",
            "name": "NHS Grampian",
            "identifier": {
                "legalName": "NHS Grampian"
            },
            "address": {
                "streetAddress": "Summerfield House, 2 Eday Road",
                "locality": "Aberdeen",
                "region": "UKM50",
                "postalCode": "AB15 6RE"
            },
            "contactPoint": {
                "email": "simon.ogg@nhs.scot",
                "telephone": "+44 3454566000",
                "url": "http://"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsgrampian.org"
            }
        },
        {
            "id": "org-168",
            "name": "SOPHiA GENETICS Ltd",
            "identifier": {
                "legalName": "SOPHiA GENETICS Ltd"
            },
            "address": {
                "streetAddress": "60 Windsor Avenue",
                "locality": "London",
                "region": "UK",
                "postalCode": "SW19 2RR"
            },
            "contactPoint": {
                "telephone": "+44 7395594261"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "url": "http://"
            }
        },
        {
            "id": "org-169",
            "name": "Aberdeen Sheriff Court and Justice of Peace Court",
            "identifier": {
                "legalName": "Aberdeen Sheriff Court and Justice of Peace Court"
            },
            "address": {
                "locality": "Aberdeen"
            },
            "contactPoint": {
                "url": "http://"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "NHS Grampian",
        "id": "org-167"
    },
    "tender": {
        "id": "OC007-25",
        "title": "Reagents and Bioinformatics analysis",
        "description": "Next Generation Sequencing (NGS) kits",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33696500",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "Aberdeen Royal Infirmary"
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM50"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationale": "We have a number of services within the department that use Next Generation Sequencing (NGS) kits supplied by SOPHiA Genetics. These services are funded by National Services division (NSD) and the Aberdeen laboratory provides National services for Hereditary Breast, Ovarian and prostate cancer, Cardiac arrhythmias and Whole exome sequencing (for metabolic, gastrohepatology, chromosome breakage / inherited bone marrow failure and eye disorders) using these SOPHiA kits. These are essential established reagents used in these testing pathways, having previously undergone extensive validation processes within the laboratory. Purchase of alternative reagents would involve delay to testing as additional extensive validation work would need to be undertaken before use. An integral bioinformatics solution, SOPHiA DDM, is included in the price of these SOPHiA kits which provides cost-effective, streamlined analysis for these patient samples. In addition, SOPHiA DDM is used to analyse NGS data for other rare and inherited conditions using tailored analysis pipelines. This includes Primary Immune Deficiencies, Familial Hypercholesterolaemia and tumour testing for metastatic prostate cancer. This is charged on a cost per sample upload basis and allows clinical scientists to analyse the data in an efficient manner without the need for specialist bioinformaticians. Purchase of bioinformatics services from another provider would take a significant amount of time for the validation work required to ensure accurate results are obtained and would incur significant costs for extensive validation. Furthermore, additional staff would be required to perform the bioinformatics processes that would be required in the absence of the SOPHiA DDM platform for all of the national genetics services mentioned above. It is vital that the supply of these items is uninterrupted as any delay will impact on patient care including cancer surgery / treatments, stem cell transplants for patients with primary immune deficiencies and bone marrow failure and correct patient management to prevent irreversible brain damage in metabolic conditions.",
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "JUL535288",
                "documentType": "awardNotice",
                "title": "Reagents and Bioinformatics analysis",
                "description": "Next Generation Sequencing (NGS) kits",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL535288",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "Award value estimated based on previous spend for 2023-24 financial year. This is a direct award to the existing supplier to save a significant amount of rework that would be required if the genetics lab was to switch to an alternative supplier. This will cover the spend for 2024-25 financial year. It is vital that the supply of these items is uninterrupted as any delay will impact on patient care including cancer surgery / treatments, stem cell transplants for patients with primary immune deficiencies and bone marrow failure and correct patient management to prevent irreversible brain damage in metabolic conditions.",
                "status": "complete",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false
            }
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_TECHNICAL",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
            }
        ],
        "classification": {
            "id": "33696500",
            "scheme": "CPV"
        },
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "awards": [
        {
            "id": "OC007-25",
            "suppliers": [
                {
                    "id": "org-168",
                    "name": "SOPHiA GENETICS Ltd"
                }
            ],
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "OC007-25",
            "awardID": "OC007-25",
            "status": "active",
            "value": {
                "amount": 376349,
                "currency": "GBP"
            },
            "dateSigned": "2025-07-21T00:00:00Z"
        }
    ],
    "language": "EN",
    "description": "(SC Ref:805164)",
    "bids": {
        "statistics": [
            {
                "id": "376",
                "measure": "bids",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "377",
                "measure": "smeBids",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "378",
                "measure": "foreignBidsFromEU",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "379",
                "measure": "foreignBidsFromNonEU",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "380",
                "measure": "electronicBids",
                "value": 1,
                "relatedLot": "1"
            }
        ]
    },
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000805164"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice"
}